Anesthetic Pharmacology and the Morbidly Obese Patient
Jerry Ingrande1, Hendrikus Jm Lemmens
1Instructor, Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Drive Room H3580, Stanford, California 94305, (phone) 650-723-7377, (fax) 650-725-8544, jerryi@stanford.edu.
Abstract:
Anesthesiologists are increasingly being faced with treating obese patients. Physiologic and anthropometric associated with obesity-most notably increases in cardiac output, changes in tissue perfusion and increases in total body weight (TBW), lean body weight (LBW), and fat mass affect the pharmacokinetics (PK) of anesthetic agents. In addition, redundancy of airway tissue, obstructive and central sleep apnea and CO2 retention affect the pharmacodynamics (PD) of anesthetics and narrow the therapeutic window of numerous anesthetic drugs. Safe and effective pharmacologic management of the obese patient requires a thorough understanding of how obesity affects the PK and PD of anesthetics.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Dosing: Obese Patients
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Stages of General Anesthesia
Inhalational Anesthetics: Overview


